1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6030E0A2A6ED3813700258A1A004457A3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-oncology-msl-team-excellence-benchmarking-key-performance-indicators?opendocument
18
19opendocument
2034.228.52.21
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Managed Care Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda Blog
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos Blog
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Field Medical Excellence

Oncology MSL Team Excellence: Benchmarking Key Performance Indicators

DB Image

Download FREE Excerpt

ID: 5776

Features:

10 Info Graphics

10 Data Graphics

90+ Metrics

10 Narratives

Pages/Slides: 25

Published: 2023

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Oncology MSL Team Excellence: Benchmarking Key Performance Indicators”

STUDY OVERVIEW

In the ever-evolving Oncology landscape, where the roles of medical science liaisons (MSLs) are shaped by both traditional and virtual dynamics, staying at the forefront of KOL engagement is a strategic imperative. To excel in this dynamic environment, it's imperative to establish and monitor key performance indicators (KPIs) that gauge field performance and impact.

Best Practices, LLC undertook benchmarking research to uncover current and emerging trends in the management of Oncology field medical teams, particularly in the context of virtual and hybrid MSLs. This study empowers Oncology field medical leaders to ensure access to key external experts and effectively measure and enhance their teams' performance and impact.


KEY TOPICS

  • Field Challenges
  • KOL Access - Post Pandemic
  • Customer Engagement Preference
  • Proactive Outreach
  • F2F Meetings: Value and Ideal Mix

KEY METRICS

  • How would you rate the post-pandemic ability of Oncology MSLs to interact with KOLs and HCPs?
  • What do KOLs and HCPs served by Oncology MSL teams prefer in terms of engagement and support?
  • Approximately how many KOLs are currently supported by an individual MSL of each type at Oncology organizations?
  • Approximately how many F2F and virtual meetings are asked of each MSL within the Oncology organization?
  • Percentage of proactive interactions in Oncology segment
  • MSL proactivity index in Oncology segment
  • Are F2F interactions assigned a higher value on the Oncology MSL scorecard?
  • How many F2F meetings are targeted monthly?

SAMPLE KEY FINDINGS

  • Proactive outreach and product-specific discussion: On average, hybrid MSLs initiate 56% of KOL interactions, proactively discussing products in 62% of these interactions.

METHODOLOGY

Best Practices, LLC engaged Field Medical and other Medical Affairs leaders from 20 top Oncology manufacturers in this research through a benchmark survey. Deep-dive interviews were also conducted with field medical leaders to capture additional insights.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care; Chemical


Companies Profiled:
AstraZeneca; Astellas; Bayer; Clovis Oncology; Eisai; Eli Lilly and Company; EMD Serono; GE Healthcare; Genentech; Ipsen; Kyowa Kirin; MacroGenics; Merck; Merus; Novartis; Pfizer; Rain Oncology; Roche; Servier; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH